Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Multiple Sclerosis

Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol. 2009 Oct 1.
Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci. 2009 Sep 30.
Antineutrophil cytoplasmic antibody-associated vasculitides: Could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum. 2009 Sep 29;61(10):1417–1424.
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol. 2009 Sep 15;183(6):3672–81.
Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann N Y Acad Sci. 2009 Sep;1173:515–20.
Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci. 2009 Sep;1173:384–90.
Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol. 2009 Sep;256(9):1468–79.
Vitamin D: In the evolution of human skin colour. Med Hypotheses. 2009 Aug 28.
Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol. 2009 Aug 18;213(1–2):135–41.
The Calcitonin / Calcitonin Gene Related Peptide-alpha Gene is not Required for 1alpha,25-Dihyrdroxyvitamin D(3)-mediated Suppression of Experimental Autoimmune Encephalomyelitis. Arch Biochem Biophys. 2009 Aug 15;488(2):105–8.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One. 2009 Aug 13;4(8):e6635.
Vitamin D, nervous system and aging. Psychoneuroendocrinology. 2009 Aug 4.
Gender differences in multiple sclerosis: Cytokines and vitamin D. J Neurol Sci. 2009 Aug 3.
Crohn's disease: The hot hypothesis. Med Hypotheses. 2009 Jul;73(1):94–6.
Vitamin D treatment in multiple sclerosis. J Neurol Sci. 2009 Jun 22.
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009 Jun 20.
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009 Jun;8(7):621–6.
Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol. 2009 Jun;22(3):219–25.
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. Mult Scler. 2009 Jun;15(6):735–40.
Multiple sclerosis and vitamin D: don't (yet) blame it on the sunshine. Brain. 2009 May;132(Pt 5):1126–7.
Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009 May;132(Pt 5):1146–60.
Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler. 2009 May;15(5):563–570.
Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult Scler. 2009 Apr;15(4):455–64.
Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5276–81.
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol. 2009 Mar 3.
Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell Mol Neurobiol. 2009 Mar;29(2):203–10.
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler. 2009 Jan;15(1):9–15.
Does vitamin D make the world go 'round'? Mol Aspects Med. 2008 Dec;29(6):369–75. Review.
Geographic location and vitamin D synthesis. Mol Aspects Med. 2008 Dec;29(6):453–61.
A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol. 2008 Dec;15(12):1273–8.
The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8. Review.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008 Nov;14(9):1220–4.
Vitamin D and multiple sclerosis. J Cell Biochem. 2008 Oct 1;105(2):338–43.
Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis. Neurology. 2008 Aug 19;71(8):583–9.
Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008 Jun;67(2–3):164–78. Review.
Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol. 2008 Feb;194(1–2):7–17. Review.
A longitudinal study of serum 25-hydroxyvitamin D and intact PTH levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152–7.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Med Hypotheses. 2008;71(1):85–90.
Therapeutic potential of vitamin D for multiple sclerosis. Curr Med Chem. 2008;15(5):499–505. Review.
Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008;70(1):66–9.
Vitamin D insufficiency—possible etiologic factor of autoimmune diseases. Ugeskr Laeger. 2007 Oct 22;169(43):3655–60. Review in Danish.
Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr. 2007 Sep;86(3):645–51.
1,25-dihydroxyvitamin D(3) reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007 Aug 15;85(11):2480–90.
Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial. 2007 Jul;20(4):316–324.
Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol. 2007 Jun;156(6):631–6.
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007 May;254(5):581–90.
Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA. 2006 Dec;296:2832–2838.
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol. 2006 Nov 1;177(9):6030–7.
Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 Oct;98(10):1024–7. Review.
Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol. 2005 Sep 15;175(6):4119–26.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006 Sep;92(1):60–4. Review.
The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006 Jun;40(6):1158–61. Review.
1,25 dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. 2006 May 15;83(7):1299–309.
Vitamin D and autoimmune disease—implications for practice from the multiple sclerosis literature. J Am Diet Assoc. 2006 Mar;106(3):418–24. Review.
Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol. 2005 Sep 15;175(6):4119–26.
Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun;10(2):94–111. Review.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. JNNP 2005;76:1294–1296.
Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004 Aug;58(8):1095–109. Review.
Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol Genomics. 2004 Jul 8;18(2):141–51.
Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60–65.
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ. 2003 Aug 9;327(7410):316.
The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277–300. Review.
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol. 2003 Jan;134(1–2):128–32.
Ultraviolet radiation and health: friend and foe. Med J Aust. 2002 Dec 2–16;177(11–12):594–8.
CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5557–60.
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002 Apr;13(3):100–5. Review.
Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2001 Sep 3;119(1):16–29.
Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000 Nov;59(4):531–5. Review.
Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000 Aug;48(2):271–2. Letter.
Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med. 2000 Jun;57(6):418–21.
1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol. 2000 Mar 1;103(2):171–9.
Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology. 2000 Feb 8;54(3):729–32.
1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59 Suppl 1:24–7. Review.
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998 Jun 1;160(11):5314–9.
Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997 Oct;216(1):21–7. Review.
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861–4.
Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiology. 1992;11(4–6):244–54.
Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology. 1987 Mar;37(3):467–71.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.